Neurocrine files for US approval for novel Parkinson’s therapy – The Pharma Letter

Neurocrine files for US approval for novel Parkinson’s therapy – The Pharma Letter
Neurocrine files for US approval for novel Parkinson's therapy  The Pharma LetterA new therapy for Parkinson's disease (PD), opicapone, will be reviewed by the US Food and Drug Administration for possible marketing approval. Neurocrine ... read more
Source: Google NewsPublished on 2019-07-11